Change in Metabolic Profile after 1-Year Nutritional-Behavioral Intervention in Obese Children

Elvira Verduci1, Carlotta Lassandro2,3, Roberta Giacchero4

  • 1Department of Pediatrics, San Paolo Hospital, Department of Health Science, University of Milan, Milan 20142, Italy. elvira.verduci@unimi.it.

Nutrients
|December 4, 2015
PubMed

Insights

A lifestyle intervention improved cardio-metabolic health in obese children. The 1-year program reduced BMI z-score, triglycerides, and insulin resistance, while increasing HDL cholesterol, benefiting metabolic syndrome markers.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Lifestyle Medicine

Background:

  • Inconsistent findings exist regarding cardio-metabolic improvements in obese children after lifestyle interventions.
  • Obesity in children is linked to adverse metabolic profiles and increased risk of metabolic syndrome.
  • Effective interventions are crucial for managing childhood obesity and its associated health complications.

Purpose of the Study:

  • To evaluate the impact of a 1-year lifestyle intervention on body mass index (BMI), blood lipid profile, glucose metabolism, and metabolic syndrome in obese children.
  • To assess changes in insulin resistance and related indices following the intervention.
  • To determine the intervention's effect on the prevalence of metabolic syndrome in the study cohort.

Main Methods:

  • A 1-year lifestyle intervention involving a normocaloric diet and physical activity was implemented.
  • Eighty-five obese children (age ≥6 years) participated in the study.
  • Measurements included BMI z-score, fasting blood lipids, insulin, glucose, HOMA-IR, HOMA-β%, QUICKI, triglyceride glucose index, and metabolic syndrome criteria.

Main Results:

  • The intervention led to a significant reduction in BMI z-score, triglycerides, and the triglyceride glucose index.
  • High-density lipoprotein (HDL) cholesterol levels increased significantly post-intervention.
  • Prevalence of insulin resistance decreased from 51.8% to 36.5%, and metabolic syndrome prevalence dropped from 17.1% to 4.9%.

Conclusions:

  • Nutritional and behavioral interventions can effectively improve blood lipid profiles and insulin sensitivity in obese children.
  • The lifestyle intervention demonstrated positive effects on metabolic syndrome markers, suggesting long-term health benefits.
  • Targeted lifestyle modifications are a viable strategy for managing cardio-metabolic risk factors in pediatric obesity.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704